|

Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches

RECRUITINGN/ASponsored by The University of Hong Kong
Actively Recruiting
PhaseN/A
SponsorThe University of Hong Kong
Started2023-12-20
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05679518

Summary

The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (i.e. stage III or IV) cancer
* are the age of 18 years or above

Exclusion Criteria:

* Patients with major communication difficulties
* are being unwilling or unable to commit 6 psychotherapy sessions

Conditions6

Advanced or Metastatic CancerCancerFear of Cancer ProgressionMetacognition-based InterventionPsychooncologySupportive-expressive Based Intervention

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.